Holdco Nuvo Group DG (Holdco Nuvo Group DG) Capex-to-Operating-Income : 0.00 (As of Dec. 2023)

View and export this data going back to 2024. Start your Free Trial

What is Holdco Nuvo Group DG Capex-to-Operating-Income?

Capex-to-Operating-Income measures a company's investments in physical assets such as property, industrial buildings or equipment to its operating income.

Holdco Nuvo Group DG's Capital Expenditure for the six months ended in Dec. 2023 was $-0.04 Mil. Its Operating Income for the six months ended in Dec. 2023 was $-16.63 Mil.

GuruFocus do not calculate Capex-to-Operating-Income if the Operating Income is negative.

Holdco Nuvo Group DG Capex-to-Operating-Income Historical Data

The historical data trend for Holdco Nuvo Group DG's Capex-to-Operating-Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Holdco Nuvo Group DG Capex-to-Operating-Income Chart

Holdco Nuvo Group DG Annual Data

Trend

Dec21

Dec22

Dec23

Capex-to-Operating-Income

Holdco Nuvo Group DG Semi-Annual Data
	Dec21	Dec22	Dec23
Capex-to-Operating-Income	-	-	-

Competitive Comparison of Holdco Nuvo Group DG's Capex-to-Operating-Income

For the Medical Devices subindustry, Holdco Nuvo Group DG's Capex-to-Operating-Income, along with its competitors' market caps and Capex-to-Operating-Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Holdco Nuvo Group DG's Capex-to-Operating-Income Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Holdco Nuvo Group DG's Capex-to-Operating-Income distribution charts can be found below:

* The bar in red indicates where Holdco Nuvo Group DG's Capex-to-Operating-Income falls into.

Holdco Nuvo Group DG Capex-to-Operating-Income Calculation

Holdco Nuvo Group DG's Capex-to-Operating-Income for the fiscal year that ended in Dec. 2023 is calculated as

Capex-to-Operating-Income	=	- Capital Expenditure	/	Operating Income
	=	- (-0.038)	/	-16.633
	=	N/A

Holdco Nuvo Group DG's Capex-to-Operating-Income for the quarter that ended in Dec. 2023 is calculated as

Capex-to-Operating-Income	=	- Capital Expenditure	/	Operating Income
	=	- (-0.038)	/	-16.633
	=	N/A

Holdco Nuvo Group DG (NAS:NUVO) Capex-to-Operating-Income Explanation

Capex-to-Operating-Income assesses how much emphasis a company is placing upon investing in capital-intensive projects. The ratio is generally a good gauge to quantify how much focus on growth a company has. Typically, smaller companies that are still growing and expanding will have a higher Capex to Operating Income Ratio, since such businesses are likely investing more in physical assets. Lower ratios could indicate that a company has reached maturity and it is no longer pursuing aggressive growth.

Holdco Nuvo Group DG Capex-to-Operating-Income Related Terms

Thank you for viewing the detailed overview of Holdco Nuvo Group DG's Capex-to-Operating-Income provided by GuruFocus.com. Please click on the following links to see related term pages.

Holdco Nuvo Group DG (Holdco Nuvo Group DG) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Holdco Nuvo Group DG Ltd (NAS:NUVO) » Definitions » Capex-to-Operating-Income

Comparable Companies

Traded in Other Exchanges

N/A

Address

94 Yigal Alon Street, Alon Tower 1, Tel Aviv, ISR, 6789155

Website

https://www.nuvocares.com

Holdco Nuvo Group DG Ltd is a women's health and connected pregnancy care company and has developed INVU by Nuvo, an FDA-cleared, prescription-initiated, remote pregnancy monitoring platform that enables the delivery of remote non-stress tests and maternal and fetal heart rate monitoring, helping expectant mothers adhere to their prescribed care plan. It is leading the transformation from a world where pregnancy care is limited by outdated technology and barriers to accessing care to a world where data-driven, clinically relevant, actionable insights can be accessed both at home and in the clinic. INVU is composed of a hardware component (wearable), with digital signal processing and cloud analytics, and interfaces for every participant involved in pregnancy care.

Holdco Nuvo Group DG (Holdco Nuvo Group DG) Headlines

From GuruFocus

Nuvo Group Adds HealthTech Veteran Adriana Machado to Board of Directors, Strengthening Company's Commitment to Transforming Prenatal Care

By Marketwired • 05-09-2024